Medication info
Nelphra Tablet 40mg (Esomeprazole Magnesium Trihydrate)

Nelphra Tablet 40mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›43.38mg / 1 tablet
Manufacturer / importer
Korea Nelson Pharmaceutical Co., Ltd.
Appearance
Pink rectangular film-coated tablets
Packaging
28 tablets (14 tablets/Alu-Alu x 2)
Approval status
Active

MFDS item code 201700551 · Approved 2017.01.31 · Insurance code 656702330

Summary

Main use
Acid-related disorders (reflux, etc.); gastrointestinal disorders caused by anti-inflammatory drugs, ulcers, and recurrent bleeding; eradication, treatment, and prevention
Who uses it
Adults · Children
Adult dosage
1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. - Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. - In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because experience in patients with severe renal failure is limited. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Adolescents aged 12 years and older: Gastroesophageal reflux disease (GERD) - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Adolescents aged 12 years and older: Gastroesophageal reflux disease (GERD) - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Korea Nelson Pharmaceutical Co., Ltd.

Efficacy & effects

Acid-related disorders (reflux, etc.); gastrointestinal disorders caused by anti-inflammatory drugs, ulcers, and recurrent bleeding; eradication, treatment, and prevention

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective for the treatment and symptom relief of gastroesophageal reflux disease and erosive esophagitis. It also helps in the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It is used for the alleviation of upper gastrointestinal symptoms and treatment of gastric ulcers due to the administration of non-steroidal anti-inflammatory drugs (NSAIDs), as well as in the prevention of gastric and duodenal ulcers. This drug is also effective for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after preventing rebleeding of gastric or duodenal ulcers. Therefore, this medication is used for the treatment and prevention of various symptoms and diseases related to gastrointestinal disorders.

Dosage and Administration

Adult dosage

1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. - Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. - In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because experience in patients with severe renal failure is limited. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Adolescents aged 12 years and older: Gastroesophageal reflux disease (GERD) - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Adolescents aged 12 years and older: Gastroesophageal reflux disease (GERD) - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. Patients with allergies to this drug or its components, or a history of hypersensitivity to the benzimidazole class, should not use it. Patients allergic to certain antibiotics used with this medication should also avoid taking it. Patients taking specific cardiac medications or antiviral agents and women who are breastfeeding should not take this medication. Care should be taken when taking this medication as various side effects may occur. Reports of various adverse reactions have been noted, including blood-related abnormalities, immune responses, electrolyte imbalance, changes in mental state, neurological symptoms, gastrointestinal issues, abnormal liver function, and skin reactions. In particular, if symptoms such as myalgia or weakness occur, immediate consultation with medical personnel is advised as there may be a serious possibility of muscle damage. Regular health check-ups are necessary if this medication is used for a long time. If gastrointestinal symptoms worsen or new symptoms appear, consulting a physician is essential. Additionally, this medication can lower gastric acidity and increase the risk of gastrointestinal bacterial infections, so if diarrhea persists, it should be communicated to healthcare providers. This medication can interact with other drugs, so if you are taking any medications, make sure to inform your doctor or pharmacist. Care should be taken especially when used with anticoagulants, antiviral agents, certain antibiotics, and anticonvulsants. The safety of this medication during pregnancy has not been fully established; thus, pregnant women should consult their physician for careful consideration before taking it. Breastfeeding women are advised not to take this medication. As there is no specific antidote for overdose, if symptoms occur, it is essential to visit a medical institution immediately for appropriate treatment. This medication should be kept out of reach of children and stored in its original packaging.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, pruritus, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane toxic syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyell syndrome, acute generalized exanthematous pustulosis, eosinophilia, drug reactions accompanied by systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, spasm, fibromyalgia syndrome, hernia, rheumatic polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, agitation, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremor, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal pruritus, rash, erythematous rash, papular rash, angioedema, dermatitis, pruritus, urticaria, increased sweating, otitis media, distorted olfaction, taste loss, taste dysfunction, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, discoid lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink rectangular film-coated tablets

Package unit

28 tablets (14 tablets/Alu-Alu x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.